jpmschweitzerandClaude Opus 4.6
68867894e9
All 36 commodity stubs fleshed out with lore context, production chain descriptions, and economic intelligence briefing voice. Key treatments: fusion_fuel (D-187 8:1 ratio), services (location-bound mechanics), brands distinguished from commodities per D-185. Co-Authored-By: Claude Opus 4.6 (1M context) <noreply@anthropic.com>
2.2 KiB
Medical Goods
| Field | Value |
|---|---|
| Name | Medical Goods |
| Tier | final |
| Elasticity | inelastic |
| Base Price (Tractus) | 200 |
| Bulk Class | compact |
| Unit | units |
| Production Ubiquity | regional |
| Demand Model | market |
| Commission Certified | Yes |
| Compact Contested | Yes |
| Shadow Viable | Yes |
| Panic Threshold (weeks) | 0 |
| Description | Pharmaceuticals, surgical equipment, diagnostics, re-embodiment supporting hardware. |
Medical goods covers certified pharmaceuticals, surgical equipment, diagnostic hardware, and the supporting physical components for licensed re-embodiment procedures. Production requires 0.4t of chemicals, 0.3 units of electronics, and 0.2t of advanced alloys — inputs from across the technology chain. Commission certification is required for formal distribution because the category includes pharmaceutical compounds and re-embodiment hardware with direct implications for patient safety and lattice compliance.
Compact contestation of Commission authority over medical goods is one of the more politically charged disputes in the certification framework. Commission oversight of re-embodiment hardware is interpreted by Compact member systems as an attempt to extend Commission jurisdiction over their citizens' neural identity infrastructure through the goods supply chain. The Tractus-denominated certification fee adds currency friction on top of the jurisdictional grievance. The result is a functioning shadow market in medical goods throughout the Compact zone — not driven by criminal demand but by communities that have collectively decided that Commission certification is not a legitimate gate on their medical autonomy.
Medical goods without certification cannot be distinguished from certified goods by physical inspection. The shadow market prices them at a discount that reflects the legal risk to the buyer, not any quality difference. In Compact territory, that discount is narrow — the political cover provided by Compact non-compliance with Commission authority reduces buyer risk substantially. In inner corridor systems, the legal exposure is larger and the shadow discount is correspondingly deeper.